Onderneming Avant Diagnostics Inc
Aandelen
US05350M1062
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01-12-17 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 24-09-20 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 12-05-16 |
Trevor McCartney
PRN | Corporate Officer/Principal | - | 01-03-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 25-05-18 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01-12-17 |
Director/Board Member | 43 | - | |
51 | - | ||
Yvonne Fors
BRD | Director/Board Member | 52 | 01-01-00 |
Matthew Schwartz
BRD | Director/Board Member | 50 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 336 957 722 | 9 119 130 ( 2,706 %) | 0 | 2,706 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
THERALINK TECHNOLOGIES, INC. 100.00% | 1 000 | 100.00% | 1 $ |
Bedrijfsgegevens
Theralink Technologies, Inc. (Colorado)
15000 West 6th Avenue Suite 400
80401, Golden
+
https://theralink.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-31,06% | 9,41 mld. | |
-8,43% | 3,03 mld. | |
+27,31% | 2,9 mld. | |
-14,31% | 2,16 mld. | |
-18,94% | 1,7 mld. | |
+73,13% | 1,51 mld. | |
+30,25% | 814 mln. | |
-1,97% | 760 mln. | |
-26,73% | 529 mln. |